|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06833 SINCO PHARMA
Nominal 
0.190 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 353,700 | 75,081 | 305,712 | 137,300 |
| Net Cash from / (used in) Investing Activities | -- | (63,626) | (119,270) | (22,727) | (46,842) |
| Net Cash from / (used in) Financing Activities | -- | (189,729) | 35,043 | (97,108) | (169,875) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 100,345 | (9,146) | 185,877 | (79,417) |
| Cash & Cash Equivalents at beginning of period | -- | 329,144 | 326,052 | 143,765 | 224,756 |
| Effect of Foreign Exchange Rate Changes | -- | 8,433 | 12,238 | (3,590) | (1,574) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 437,922 | 329,144 | 326,052 | 143,765 |
| Remarks: | Real time quote last updated: 18/11/2024 13:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 23,870 |
| %Change | 21.817% |
| EPS / (LPS) | RMB 0.012 |
| NBV Per Share (¥) | RMB 0.317 |